Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. latamerica
  4. therapeutic candidate
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Videos

Refine by
Date

  • This Year
  • Older

Therapeutic Candidate Articles & Analysis

19 articles found

Could a Novel BET Inhibitor Protect the Lungs from Secondhand Smoke?

Could a Novel BET Inhibitor Protect the Lungs from Secondhand Smoke?

A recent study from Sturgis et al. (2025) has demonstrated a promising new therapeutic candidate: VYN202, a small-molecule bromodomain and extra-terminal (BET) inhibitor. ...

BySCIREQ - an emka TECHNOLOGIES Company


CCR1 Protein: A Chemokine Receptor at the Crossroads of Immunity and Disease

CCR1 Protein: A Chemokine Receptor at the Crossroads of Immunity and Disease

This contextual behavior makes CCR1 a prime candidate for therapeutic modulation. Unlike receptors with highly selective ligand pools, CCR1’s redundancy ensures robustness of immune response but complicates therapeutic targeting. ...

ByCreative BioMart


Recombinant MGP Protein: A Key Tool for Studying Vascular Calcification and Tissue Mineralization

Recombinant MGP Protein: A Key Tool for Studying Vascular Calcification and Tissue Mineralization

The development of recombinant MGP protein has enabled researchers to study the molecular mechanisms of calcification control and evaluate therapeutic interventions in a variety of disease contexts. This article explores the biological function of MGP, the applications of its recombinant form in experimental settings, and the relevance of MGP-based research in understanding ...

ByCreative BioMart


Innovative Preclinical Alfa Cytology alfaCAR-T Solutions: Revolutionizing the CAR-T Development Platform

Innovative Preclinical Alfa Cytology alfaCAR-T Solutions: Revolutionizing the CAR-T Development Platform

By fostering an environment of innovation and collaboration, Alfa Cytology not only advances its therapeutic candidates but also contributes to the broader field of cancer research. ...

ByAlfa Cytology


Antibody Drug Design: Advancements and Innovations

Antibody Drug Design: Advancements and Innovations

This specificity and versatility make antibodies attractive candidates for therapeutic applications. The Evolution of Antibody Drug Design Traditional methods of drug development often involved trial-and-error approaches to identify suitable candidates. ...

ByCreative Biogene


Single-Domain Antibody Production: A Comprehensive Overview

Single-Domain Antibody Production: A Comprehensive Overview

This stability makes them suitable candidates for therapeutic use and allows for diverse storage conditions. ...

ByCreative Biogene


Comprehensive Disease Models for Preclinical Drug Discovery

Comprehensive Disease Models for Preclinical Drug Discovery

Preclinical drug discovery represents a critical phase in the development of new therapeutics. It is the process that bridges the gap between basic research and clinical testing, allowing for the evaluation of potential drug candidates in biological systems before they are tested in humans. ...

ByCreative Biogene


Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

Advancements in Breast Cancer Research: The Role of Tumor Models and Customized ADCs Development Services

These advancements not only enhance our understanding of the disease but also pave the way for more targeted therapeutic solutions. Tumor models for breast cancer, which include both in vivo and in vitro systems, are crucial for studying the complexities of tumor biology and testing potential treatments. ...

ByAlfa Cytology


Advancements in mRNA Delivery: A New Era in Therapeutics

Advancements in mRNA Delivery: A New Era in Therapeutics

This article explores the latest advancements in mRNA delivery systems and their implications for future therapeutic applications. Understanding mRNA and Its Role mRNA serves as a blueprint for protein synthesis within cells. ...

ByCreative Biogene


AI and Multiplex Cloning Redefine Aantibody Discovery

AI and Multiplex Cloning Redefine Aantibody Discovery

This not only integrates the advantages of various methods but also accelerates the early discovery stage of therapeutic development. In situations where computer simulation analysis and AI-driven antibody discovery run parallel to in vivo methods, we are expected to predict and prioritize potential antibody candidates. ...

ByMtoZ Biolabs


Understanding the Importance of Preclinical Animal Models in Drug Development

Understanding the Importance of Preclinical Animal Models in Drug Development

By simulating the disease in question, scientists can investigate disease progression, identify potential therapeutic targets, and evaluate the efficacy of novel drug candidates. ...

ByCreative Bioarray


Predicting cardiotoxicity with engineered 3D human cardiac tissue models

Predicting cardiotoxicity with engineered 3D human cardiac tissue models

IVS technology improves clinical approval success rates by predicting patients’ responses to drug candidates which is achieved by using the tissue-based discovery platform to predict patient-specific responses to treatments in engineered human tissues derived from patient-specific samples. ...

ByInvivoSciences, Inc. (IVS)


Painting the Picture of Recursion

Painting the Picture of Recursion

We tend to be so specialized that it’s difficult to fund a team bringing the necessary expertise together to push potential therapeutics along the pathway. I knew it would be incredibly rewarding to see these two lead a company and carry out their vision. ...

ByRecursion


Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus

Rational Vaccines Announces a Clinical Trial to Determine Baseline Characteristics of Patients Diagnosed With Recurrent Symptomatic Herpes Simplex Type 2 (HSV-2) Virus

Results will inform protocol design of Phase 1/2 clinical trial of Company's lead HSV-2 therapeutic vaccine candidate WOBURN, Mass. and OXFORD, England, Aug. 15, 2022 /PRNewswire/ -- Rational Vaccines, a company focused on revolutionizing the treatment and prevention of herpes to eradicate the disease, today announced the launch of a clinical trial designed to ...

ByRational Vaccines, Inc.


Using AI to Fight a Pandemic: Insilico Medicine Announces Novel Preclinical Candidate for COVID-19 Treatment

Using AI to Fight a Pandemic: Insilico Medicine Announces Novel Preclinical Candidate for COVID-19 Treatment

Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. ...

ByInsilico Medicine


Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma

Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma

This study describes the functional kinomic landscape of Ras/p53 mutant chemically-induced squamous cell carcinoma in both the baseline unperturbed state and following DNA damage and nominates candidate therapeutic targets, including the Nek4 kinase, for further development. ...

BySEngine Precision Medicine


Cell Transplantation Promising for Treatment of Biliary Diseases   

Cell Transplantation Promising for Treatment of Biliary Diseases  

It has been demonstrated that both transplanted bile duct cells and hepatocyte-derived cells produce biliary regeneration in mice, which fully demonstrates the therapeutic potential of BECs in liver diseases. However, the use of human BECs (hBECs) in the clinical setting remains limited. ...

ByCreative Biolabs


Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning

Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning

Here we outline how machine learning, advances in viral immunology, and high-throughput measurements can enable engineering of a new generation of de-immunized capsids beyond the antigenic landscape of natural AAVs, towards expanding the therapeutic reach of gene therapy. Introduction Recently approved AAV-based therapeutics and numerous ...

ByDyno Therapeutics


Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota

Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota

Previous studies suggested that L. rhamnosusshowed the therapeutic effects for AD.42–44 Especially, L. rhamnosus GG is widely reported strain for AD prevention and treatment.43,44 Therefore, in this study, we used L. rhamnosus KBL365, isolated from healthy Korean feces, to confirm the effects of L. paracasei on AD. Although some L. rhamnosus strains suppress the progression ...

ByKoBioLabs

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT